Acrux heads to the Finnish

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.

Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.

Acrux retains the rights to supply the products to licensees in all territories.

Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.

Related News

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd